Compare EQH & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | VANI |
|---|---|---|
| Founded | 1859 | 1998 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Specialty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 100.0M |
| IPO Year | N/A | 2014 |
| Metric | EQH | VANI |
|---|---|---|
| Price | $42.70 | $1.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $56.82 | $3.50 |
| AVG Volume (30 Days) | ★ 3.6M | 187.0K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.60% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,000,000.00 |
| Revenue This Year | $43.13 | N/A |
| Revenue Next Year | $7.45 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.20 | $0.92 |
| 52 Week High | $56.61 | $1.92 |
| Indicator | EQH | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 55.62 | 46.97 |
| Support Level | $42.30 | $1.15 |
| Resistance Level | $44.17 | $1.26 |
| Average True Range (ATR) | 1.48 | 0.07 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 59.65 | 26.13 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.